Ruth Halaban
- Oncology top 10%
- Molecular Biology
- Cell Biology top 5%
- Immunology
- Cancer Research
- Co-authors
- Janet M. CowanGisela MoellmannMark H. StolerGlynis ScottJeannette BennicelliDorothee HerlynZ SteplewskiMeenhard Herlyn
- Topics
- Melanoma and MAPK Pathways (6 papers)RNA regulation and disease (4 papers)melanin and skin pigmentation (4 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Ruth Halaban
15 papers receiving 769 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 389
- Molecular Biology 381
- Cell Biology 230
- Immunology 205
- Cancer Research 117
Countries citing papers authored by Ruth Halaban
This map shows the geographic impact of Ruth Halaban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Halaban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Halaban more than expected).
Fields of papers citing papers by Ruth Halaban
This network shows the impact of papers produced by Ruth Halaban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Halaban. The network helps show where Ruth Halaban may publish in the future.
Co-authorship network of co-authors of Ruth Halaban
This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Halaban. A scholar is included among the top collaborators of Ruth Halaban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Halaban. Ruth Halaban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 9 | |
| 7 | T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanomabreakdown → | 180 |
| 8 | 1 | |
| 9 | 26 | |
| 10 | 1 | |
| 11 | 69 | |
| 12 | 47 | |
| 13 | 37 | |
| 14 | 80 | |
| 15 | 49 | |
| 16 | 163 | |
| 17 | Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. | 123 |
About Ruth Halaban
Ruth Halaban is a scholar working on Cell Biology, Immunology and Oncology, having authored 17 papers that have together received 795 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), RNA regulation and disease (4 papers) and melanin and skin pigmentation (4 papers). The work is most often cited by research in Oncology (389 citations), Cell Biology (230 citations) and Immunology and Allergy (64 citations). Ruth Halaban has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Janet M. Cowan, Gisela Moellmann, Mark H. Stoler, Glynis Scott, Jeannette Bennicelli, Dorothee Herlyn, Z Steplewski, Meenhard Herlyn, Gloria Balaban and Aaron M. Newman. Their work appears in journals such as Nature Medicine, JNCI Journal of the National Cancer Institute and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.